Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Pharmaceuticals
Sanaria and the PATH Malaria Vaccine Initiative (MVI) have opened a plant in Rockville, Md., to manufacture the first vaccine using a weakened malaria parasite. Overcoming obstacles to large-scale production, Sanaria's approach involves safely raising aseptically produced mosquitoes carrying Plasmodium falciparum, irradiating them to weaken the parasite, and then harvesting the parasite from the insects' salivary glands. Sanaria plans to begin clinical testing next year. Along with MVI, Sanaria has support from NIH and the Department of Defense.
This article has been sent to the following recipient: